Last reviewed · How we verify
NCT04410029
Evaluation of a Decision Aid for Early Pregnancy Loss
NA trial testing Healthwise Decision Aid in Early Pregnancy Loss in 60 participants. Completed in 25 March 2021.
23 March 2021
Quick facts
| Lead sponsor | University of Pennsylvania |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 60 |
| Start date | 29 July 2020 |
| Primary completion | 23 March 2021 |
| Estimated completion | 25 March 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Healthwise Decision Aid
- Control informational handout
Conditions studied
- Early Pregnancy Loss — all drugs for Early Pregnancy Loss →
Sponsor
University of Pennsylvania
Who can join
18 and older, female only, with Early Pregnancy Loss. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to determine the effect of the Healthwise decision aid on shared decision making in women undergoing management of early pregnancy loss.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Decision aids for people facing health treatment or screening decisions.
Stacey D, Lewis KB, Smith M, Carley M, et al · · 2024 · cited 203× · PMID 38284415 · DOI 10.1002/14651858.cd001431.pub6
Verify or expand the search:
- PubMed search for NCT04410029
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Early Pregnancy Loss
Currently open trials in the same condition.
- NCT06647849 — Interest of Simulation Training on the Announcement of Early Pregnancy Loss on the Psychological Impact of the Patients · NA · recruiting
- NCT06452719 — Letrozole and Misoprostol for Early Pregnancy Loss Management · Phase 2 · recruiting
- NCT05880381 — Virtual Reality for Coping With Involuntary Early Pregnancy Loss · NA · recruiting
- NCT04595760 — Factors Influencing Fertility or Pregnancy Health · active not recruiting
Other University of Pennsylvania trials
Trials by the same sponsor.
- NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
- NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
- NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
- NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
- NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04410029 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
- Last refreshed: 29 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04410029.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing